Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
890
-
Total shares
-
35.4M
-
Shares change
-
-3.99M
-
Total reported value, excl. options
-
$5.15B
-
Value change
-
-$573M
-
Put/Call ratio
-
1.63
-
Number of buys
-
307
-
Number of sells
-
-385
-
Price
-
$145.60
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2024
filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q3 2024.
ISHARES TR - ISHARES BIOTECH (IBB) has 890 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.4M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (7.15M shares), MORGAN STANLEY (3.16M shares), BNP PARIBAS FINANCIAL MARKETS (2.38M shares), CITIGROUP INC (1.98M shares), Royal Bank of Canada (1.47M shares), JANE STREET GROUP, LLC (1.44M shares), GOLDMAN SACHS GROUP INC (1.37M shares), UBS Group AG (878K shares), WELLS FARGO & COMPANY/MN (783K shares), and COMMERCE BANK (743K shares).
This table shows the top 890 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.